Alkem Laboratories says USFDA inspection at Taloja facility ends with 'zero' observations

The US Food and Drug Administration (USFDA) had conducted a remote and virtual bio-analytical inspection of the company's Bioequivalence Center located at Taloja, Maharashtra from July 26-28, 2021, Alkem Laboratories said in a regulatory filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3zNNMA0
via IFTTT